Rapid carvedilol up-titration in hospitalized patients with systolic heart failure. 2008

Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
Division of Cardiology, Hospital Universitario Gregorio Marañón, Madrid, Spain. mmselles@secardiologia.es

To determine whether carvedilol can be safely up-titrated before hospital discharge, we studied 372 consecutive patients with systolic heart failure who were being treated with carvedilol. Carvedilol was initiated a median of 3 days after admission, with a mean starting dose of 12 mg. Up-titration was performed in 67% of patients, with a mean increase of 16 mg and a mean discharge daily dose of 23 +/- 17 mg. Mean daily dose at the end of follow-up was 35.3 +/- 25.3 mg and it increased with higher discharge dose.

UI MeSH Term Description Entries
D007297 Inpatients Persons admitted to health facilities which provide board and room, for the purpose of observation, care, diagnosis or treatment. Inpatient
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011412 Propanolamines AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives. Aminopropanols
D002227 Carbazoles Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077261 Carvedilol A carbazole and propanol derivative that acts as a non-cardioselective beta blocker and vasodilator. It has blocking activity for ALPHA 1 ADRENERGIC RECEPTORS and, at higher doses, may function as a blocker of CALCIUM CHANNELS; it also has antioxidant properties. Carvedilol is used in the treatment of HYPERTENSION; ANGINA PECTORIS; and HEART FAILURE. It can also reduce the risk of death following MYOCARDIAL INFARCTION. BM 14190,BM-14190,Carvedilol Hydrochloride,Carvedilol, (+),Carvedilol, (+)-isomer,Carvedilol, (+-)-isomer,Carvedilol, (-),Carvedilol, (-)-isomer,Carvedilol, (R)-isomer,Carvedilol, (S)-isomer,Carvedilol, 14C-labeled,Coreg,Coropres,Dilatrend,Eucardic,Kredex,Querto,14C-labeled Carvedilol,BM14190,Carvedilol, 14C labeled
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
January 2005, The American journal of geriatric cardiology,
Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
September 2001, American heart journal,
Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
February 2012, Journal of cardiovascular pharmacology,
Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
October 2006, Heart, lung & circulation,
Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
December 2007, Cardiovascular drugs and therapy,
Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
May 2004, The American journal of cardiology,
Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
August 2016, International journal of cardiology,
Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
June 2004, Journal of cardiac failure,
Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
April 2006, American heart journal,
Manuel Martínez-Sellés, and Tomás Datino, and Marta Alhama, and Nelida Barrueco, and Isabel Castillo, and Francisco Fernández-Avilés
February 2007, JAMA,
Copied contents to your clipboard!